Trials / Completed
CompletedNCT06768229
Survival Plant-Based
Single Arm, Open-label, Single-center Exploratory Study to Assess the Survival of Bifidobacteria's Strains in Human Gastro-intestinal Tract of Healthy Volunteers After 14 Days of Consumption of a Mix of 4 Freeze-dried Strains.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Danone Global Research & Innovation Center · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to explore the potential of a mix of 4 freeze-dried bifidobacteria strains from Danone collection to survive in human gastro-intestinal (GI) tract of healthy volunteers after 14 days of consumption. To this aim, one study group of 20 healthy volunteers will consume freeze-dried strains- mix twice per day diluted in 1 glass of still water during 14 consecutive days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Consumption of a freeze-dried strains-mix. | One study group of 20 healthy volunteers will consume freeze-dried strains-mix twice per day diluted in 1 glass of still water during 14 consecutive days. |
Timeline
- Start date
- 2025-01-09
- Primary completion
- 2025-03-14
- Completion
- 2025-05-13
- First posted
- 2025-01-10
- Last updated
- 2025-06-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06768229. Inclusion in this directory is not an endorsement.